Trial Profile
Multicenter Prospective, Parallel-controlled Phase III Clinical Study on Comparing Efficacy of Tamoxifen Versus Toremifene in CYP2D6 Intermediate/Poor Metabolizers of Premenopausal Patients With ER-positive Early Breast Cancer
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Tamoxifen (Primary) ; Toremifene (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- 24 Nov 2017 New trial record